Surgical Meshes Impregnated with Manuka Honey Fight Infections
By HospiMedica International staff writers Posted on 17 Dec 2019 |
Image: Dr. Piergorgio Gentile and Manuka honey (Photo courtesy of Newcastle University)
Sandwiching tiny amounts of Manuka honey between surgical mesh layers can provide protection against bacterial infection for up to three weeks, according to a new study.
Developed by researchers at Ulster University (Newtownabbey, United Kingdom), the University of Leeds (United Kingdom), Newcastle University (United Kingdom), and other institutions, the surgical mesh was created via layer-by-layer (LBL) nanotechnology assembly by sandwiching eight layers each of negatively charged Manuka honey nanolayers and a positively charged biomimetic electrospun poly(ε-caprolactone) polymer. Each layer was just 10-20 nm in thickness.
Different cell lines, including human immortalized and primary skin fibroblasts, and primary endothelial cells, were exposed to the mesh to confirm membrane cytocompatibility. The Manuka honey meshes were then exposed to various Gram-negative and Gram-positive bacteria responsible for infections in the body, such as Staphylococcus, methicillin-resistant Staphylococcus aureus (MRSA), and E. coli. The results showed that antimicrobial MH activity was dependent on the concentration used, and the strains tested. The study was published on December 4, 2109, in Frontiers in Bioengineering and Biotechnology.
“Honey has been used to treat infected wounds for thousands of years, but this is the first time it has been shown to be effective at fighting infection in cells from inside the body,” said senior author Piergorgio Gentile, PhD, of Newcastle University. “Similarly layered antibiotic-releasing coatings to protect implants against bacterial infection have been judged as failing to provide durable protection, as it could encourage the development of drug resistant bacterial strains.”
Manuka (Leptospermum) honey is made from the tree species Leptospermum, found in New Zealand and Australia. The antibacterial effect of Manuka honey is due to the presence of methylglyoxal (MGO), which forms from the compound dihydroxyacetone (DHA) present in nectar, and converted into MGO during the ripening of honey. The level of MGO in Manuka honey is 100 or more times higher than in other types of honey.
Related Links:
Ulster University
University of Leeds
Newcastle University
Developed by researchers at Ulster University (Newtownabbey, United Kingdom), the University of Leeds (United Kingdom), Newcastle University (United Kingdom), and other institutions, the surgical mesh was created via layer-by-layer (LBL) nanotechnology assembly by sandwiching eight layers each of negatively charged Manuka honey nanolayers and a positively charged biomimetic electrospun poly(ε-caprolactone) polymer. Each layer was just 10-20 nm in thickness.
Different cell lines, including human immortalized and primary skin fibroblasts, and primary endothelial cells, were exposed to the mesh to confirm membrane cytocompatibility. The Manuka honey meshes were then exposed to various Gram-negative and Gram-positive bacteria responsible for infections in the body, such as Staphylococcus, methicillin-resistant Staphylococcus aureus (MRSA), and E. coli. The results showed that antimicrobial MH activity was dependent on the concentration used, and the strains tested. The study was published on December 4, 2109, in Frontiers in Bioengineering and Biotechnology.
“Honey has been used to treat infected wounds for thousands of years, but this is the first time it has been shown to be effective at fighting infection in cells from inside the body,” said senior author Piergorgio Gentile, PhD, of Newcastle University. “Similarly layered antibiotic-releasing coatings to protect implants against bacterial infection have been judged as failing to provide durable protection, as it could encourage the development of drug resistant bacterial strains.”
Manuka (Leptospermum) honey is made from the tree species Leptospermum, found in New Zealand and Australia. The antibacterial effect of Manuka honey is due to the presence of methylglyoxal (MGO), which forms from the compound dihydroxyacetone (DHA) present in nectar, and converted into MGO during the ripening of honey. The level of MGO in Manuka honey is 100 or more times higher than in other types of honey.
Related Links:
Ulster University
University of Leeds
Newcastle University
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration